HAMILTON THORNE ENGAGES INVESTOR RELATIONS FIRM
BEVERLY, MA and TORONTO, Ontario – June 16, 2014 – Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has engaged Investor Cubed Inc. (“Investor Cubed”) to provide investor relations services. Investor Cubed will be focused on increasing investor awareness while introducing Hamilton Thorne to its network of investment contacts.
David Wolf, Hamilton Thorne’s President and CEO, commented, “Hamilton Thorne’s management team is committed to raising market awareness for the Company. Appointing Investor Cubed brings an experienced investor relations group with broad industry contacts to our team, and their expertise in communicating the Company’s message to the public markets will be important.”
Alan Huycke, Investor Cubed’s President, comments, “We are pleased to be working with Hamilton Thorne. It is a leader in its field with a proven track record of solid quarter over quarter revenue and net income growth. We believe the company represents a unique opportunity for both value and growth oriented investors in the small cap sector.”
About Hamilton Thorne Ltd. (www.hamiltonthorne.com)
Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced imaging systems for the fertility, stem cell and developmental biology research markets. It provides novel solutions for Life Science that reduce cost, increase productivity, improve results and enable research breakthroughs in fertility, regenerative medicine, and stem cell research markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF procedures. Its imaging systems improve outcomes in human IVF clinics and animal breeding facilities and provide high-end toxicology analyses.
Hamilton Thorne’s growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge.
About Investor Cubed Inc. (www.investor3.ca)
Investor Cubed provides specialized consulting services to a select group of leading emerging and mid-capitalization companies, with an objective of taking its clients to the next level. Investor Cubed assists these companies in gaining exposure to an established national network of financial industry professionals. This broad network includes investment advisors, bank owned investment dealers and leading independent financial firms. In addition, Investor Cubed provides traditional investor relations services including tailored national marketing and communications strategies.
Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.
Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at www.sedar.com.
For more information, please contact:
Investor Cubed Inc.:
info [AT] investor3 [DOT] ca